To ensure that the SMG1 inhibition was not affecting the immunogenicity of the tumor by other mechanisms not directly related to the antigen expression under NMD control, we first confirmed that MHC-I expression was not altered in SMG1KD tumors (Fig. S8A). The gene discussed is SMG1; the disease is neoplasm.